DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.

Author(s): McGregor BA, Brown AW, Osswald MB, Savona MR

Affiliation(s): Department of Medicine, Hematology-Oncology, San Antonio Military Medical Center, San Antonio, Texas, USA.

Publication date & source: 2009-04, Am J Hematol., 84(4):228-30.

Publication type: Case Reports; Review

The standard dose of clofarabine is 52 mg/m2 for pediatrics and 40 mg/m2 in adults. Clofarabine dosed at 52 mg/m2 was used in adult patients with refractory ALL to maximize response before allo-HSCT. All patients had a significant response to therapy. Published pharmacokinetic analysis revealed no difference in peak plasma or intracellular concentrations at clofarabine dosed above 40 mg/m2, yet inhibition of replication in leukemia cells was only sustained over 24 hr at 55 mg/m2. Despite this, there have been no reports of high dose clofarabine used in this setting. Our experience implies that there may be a niche role for clofarabine in reducing disease burden before allo-HSCT for adults with relapsed ALL. Copyright 2009 Wiley-Liss, Inc.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017